COVID-19 boosters have arrived — and with them, of course, plenty of debate. While health and administration officials reportedly remain at odds over the proper timeline in which to roll out third doses, unvaccinated hold-outs stand steadfast in their relunctance, writes The New York Times, perhaps even hardening in their skepticism thanks to the "mixed messages" from the booster campaign.
"It seems like such a short time and people are already having to get boosters," said Christopher Poe, an unvaccinated manufacturing worker who grew more skeptical about the shot due to the third-dose discourse. "And the fact that they didn't realize that earlier in the rollout shows me that there could be other questions that could be out there, like the long-term effects."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The result is "really two different types of campaigns" in the U.S., Dr. Jennifer Avegno, director of the New Orleans health department, told the Times. Physicians are encouring vaccinated the vaccinated to come in for boosters while simulataneously struggling "to defend the need for the third shot to those who have yet to get their first."
Meanwhile, an FDA advisory panel will meet Thursday and Friday to debate booster doses of both the Moderna and Johnson & Johnson vaccines, CNBC reports. Currently, only Pfizer and BioNTech's vaccine has been authorized for use.
As of Saturday, over 7 million Americans had received a booster dose. Read more at The New York Times and CNBC.
-
Roasted squash and apple soup recipeThe Week Recommends Autumnal soup is full of warming and hearty flavours
-
Ukraine: Donald Trump pivots againIn the Spotlight US president apparently warned Volodymyr Zelenskyy to accept Vladimir Putin’s terms or face destruction during fractious face-to-face
-
Autumn Budget: will Rachel Reeves raid the rich?Talking Point To fill Britain’s financial black hole, the Chancellor will have to consider everything – except an income tax rise
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
